Segment Information

12 Months Ended

Jun. 30, 2014

Segment Reporting [Abstract]

Segment Information

(19) Segment Information

The Company’s business is organized along product lines into three principal segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals.  In fiscal 2012, the Company reconfigured and renamed its three business segments to more accurately reflect the scope of its business activities.

Human Health - includes finished dosage form generic drugs and nutraceutical products.

Pharmaceutical Ingredients – includespharmaceutical intermediates and active pharmaceutical ingredients (APIs).

Performance Chemicals - The Performance Chemicals segment is made up of two product groups: Specialty Chemicals and Agriculture Protection Products. Specialty chemicals includes a variety of chemicals which make plastics, surface coatings, textiles, fuels and lubricants perform to their designed capabilities. Dye and pigment intermediates are used in the color-producing industries such as textiles, inks, paper, and coatings. Organic intermediates are used in the production of agrochemicals. In addition, Aceto is a supplier of diazos and couplers to the paper, film and electronics industries.

Agricultural Protection Products includes herbicides, fungicides and insecticides that control weed growth as well as control the spread of insects and other microorganisms that can severely damage plant growth. The Agricultural Protection Products segment also includes a sprout inhibitor for potatoes and an herbicide for sugar cane.

The Company’s chief operating decision maker evaluates performance of the segments based on net sales, gross profit and income before income taxes. Unallocated corporate amounts are deemed by the Company as administrative, oversight costs, not managed by the segment managers. The Company does not allocate assets by segment because the chief operating decision maker does not review the assets by segment to assess the segments’ performance, as the assets are managed on an entity-wide basis.During all periods presented, our chief operating decision maker has been the Chief Executive Officer of the Company.In accordance with GAAP,  the Company has aggregated certain operating segments into reportable segments because they have similar economic characteristics, and the operating segments are similar in all of the following areas:  (a) the nature of the products and services; (b) the nature of the production processes; (c) the type or class of customer for their products and services; (d) the methods used to distribute their products or provide their services; and (e) the nature of the regulatory.

	Human  Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated  Totals
2014
Net sales	$	160,217	$	176,425	$	173,537	$	-		$	510,179
Gross profit		48,496		36,615		29,592		-			114,703
Income before income taxes		19,710		17,557		13,273		(5,866	)		44,674
2013
Net sales	$	129,667	$	184,852	$	185,171	$	-		$	499,690
Gross profit		39,306		31,367		27,598		-			98,271
Income before income taxes		17,276		13,294		10,400		(6,420	)		34,550
2012
Net sales	$	105,249	$	162,998	$	176,141	$	-		$	444,388
Gross profit		29,932		25,472		26,628		-			82,032
Income before income taxes		11,683		8,066		10,570		(5,579	)		24,740

Net sales and gross profit by source country for the years ended June 30, 2014, 2013 and 2012 were as follows:

	Net Sales						Gross Profit
	2014		2013		2012		2014		2013		2012
United States	$	355,715	$	326,247	$	289,630	$	82,573	$	68,964	$	58,733
Germany		84,024		92,053		82,600		22,614		19,688		14,303
Netherlands		14,869		14,513		13,738		1,581		1,693		1,706
France		29,412		38,475		33,143		4,182		4,608		3,885
Asia-Pacific		26,159		28,402		25,277		3,753		3,318		3,405
Total	$	510,179	$	499,690	$	444,388	$	114,703	$	98,271	$	82,032

Sales generated from the United States to foreign countries amounted to $31,156, $36,976 and $37,892 for the fiscal years ended June 30, 2014, 2013 and 2012, respectively.

Long-lived assets by geographic region as of June 30, 2014 and June 30, 2013 were as follows:

	Long-lived assets
	2014		2013
United States	$	160,544	$	80,870
Europe		3,458		2,684
Asia-Pacific		2,042		2,213
Total	$	166,044	$	85,767